Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Opposing actions of TLR2 and TLR4 in adipocyte differentiation and mature-onset obesity

  • Cuesta, Natalia
  • Fernández-Veledo, Sonia
  • Punzón, Carmen
  • Moreno, Cristobal
  • Barrocal, Beatriz
  • Sreeramkumar, Vinatha
  • Desco Menéndez, Manuel
  • Fresno, Manuel
This article belongs to the Special Issue State-of-the-Art Biochemistry in Spain., Understanding the signaling cascades that govern adipocyte metabolism and differentiation is necessary for the development of therapies for obesity. Toll-like receptors (TLRs) are key mediators in adipogenesis, but their specific role is not completely understood. In this study, siRNA knockdown of Tlr2 in 3T3-L1 cells allowed them to differentiate more efficiently into adipocytes, whereas the opposite was observed for the knockdown of Tlr4. At the same time, we show that TLR2 knock-out mice spontaneously developed mature-onset obesity and insulin resistance. Besides a higher incidence of hyperplasia and hypertrophy in white adipose tissue (WAT), we found a significantly increased number of adipocyte precursor cells in TLR2−/− mice compared to TLR4−/− mice. Interestingly, genetic inactivation of Tlr4 in TLR2−/− mice reverted their increased adiposity, insulin resistance, and restored normal levels of adipocyte precursor cells. These findings provide evidence that TLR2 and TLR4 play opposing roles in WAT homeostasis and point to the existence of cross-regulation among TLR2 and TLR4 during adipocyte differentiation both in vitro and in vivo., This research was funded by the Spanish Ministry of Sciences and Innovation and MINECO (SAF2010-18733 and SAF2016-75988-R), from European Union H2020-MSC-ETN-642157 project TOLLerant, and from the Community of Madrid S2017/BMD-3671 INFLAMUNE-CM to MF as well as Institutional grants from "Fundación Ramón Areces" and "Banco de Santander" to CBMSO.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Antibiotic capture by bacterial lipocalins uncovers an extracellular mechanism of intrinsic antibiotic resistance

  • El-Halfawy, Omar M.
  • Klett Arroyo, Javier
  • Ingram, Rebecca J.
  • Loutet, Slade A.
  • Murphy, Michael E. P.
  • Martín Santamaría, Sonsoles
  • Valvano, Miguel A.
The potential for microbes to overcome antibiotics of different classes before they reach bacterial cells is largely unexplored. Here we show that a soluble bacterial lipocalin produced by Burkholderia cenocepacia upon exposure to sublethal antibiotic concentrations increases resistance to diverse antibiotics in vitro and in vivo. These phenotypes were recapitulated by heterologous expression in B. cenocepacia of lipocalin genes from Pseudomonas aeruginosa, Mycobacterium tuberculosis, and methicillin-resistant Staphylococcus aureus. Purified lipocalin bound different classes of bactericidal antibiotics and contributed to bacterial survival in vivo. Experimental and X-ray crystal structure-guided computational studies revealed that lipocalins counteract antibiotic action by capturing antibiotics in the extracellular space. We also demonstrated that fat-soluble vitamins prevent antibiotic capture by binding bacterial lipocalin with higher affinity than antibiotics. Therefore, bacterial lipocalins contribute to antimicrobial resistance by capturing diverse antibiotics in the extracellular space at the site of infection, which can be counteracted by known vitamins., This work was funded by grants from Cystic Fibrosis Canada, the European Commission, a Marie Curie Career Integration grant (projects 618095, NONANTIRES), and the Infection and Immunity Translational Research Group, Northern Ireland HSC to M.A.V.; the Spanish Ministry for Economy and Competitiveness (MINECO CTQ2011-22724 and CTQ2014-57141-R), European Commission Marie Curie grants GLYCOPHARM FP7-PITN-GA-2012-317297 and TOLLerant H2020-MSC-ETN-642157 to S.M.S.; and Canadian Institutes of Health research grant MOP-49597 and a grant from Cystic Fibrosis Canada to M.E.P.M. An Ontario Graduate Scholarship supported O.M.E.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

SIMPLE: structured illumination based point localization estimator with enhanced precision

  • Reymond, Loïc
  • Ziegler, Johannes
  • Knapp, Christian
  • Wang, Fung-Chen
  • Huser, Thomas
  • Ruprecht, Verena
  • Wieser, Stefan
We present a structured illumination microscopy based point localization estimator (SIMPLE) that achieves a 2-fold increase in single molecule localization precision compared to conventional centroid estimation methods. SIMPLE advances the recently introduced MINFLUX concept by using precisely phase-shifted sinusoidal wave patterns as nanometric rulers for simultaneous particle localization based on photon count variation over a 20 μm field of view. We validate SIMPLE in silico and experimentally on a TIRF-SIM setup using a digital micro-mirror device (DMD) as a spatial light modulator., Funding: “la Caixa” Foundation (ID 100010434, LCF/BQ/IN18/11660032); Marie Skłodowska-Curie Horizon 2020 (713673, 754558, 642157); Spanish Ministry Centro de Excelencia Severo Ochoa (SEV-2015-0522); MINECO’s Plan Nacional (BFU2017-86296-P); Generalitat de Catalunya (CERCA); Fundació Privada Cellex
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Co-administration of antimicrobial peptides enhances toll-like receptor 4 antagonist activity of a synthetic glycolipid

  • Facchini, Fabio A.
  • Coelho, Helena
  • Sestito, Stefania Enza
  • Delgado, Sandra
  • Minotti, Alberto
  • Andreu Martínez, David
  • Jiménez-Barbero, Jesús J.
  • Peri, Francesco
This study examines the effect of co-administration of antimicrobial peptides and the synthetic glycolipid FP7, which is active in inhibiting inflammatory cytokine production caused by TLR4 activation and signaling. The co-administration of two lipopolysaccharide (LPS)-neutralizing peptides (a cecropin A-melittin hybrid peptide and a human cathelicidin) enhances by an order of magnitude the potency of FP7 in blocking the TLR4 signal. Interestingly, this is not an additional effect of LPS neutralization by peptides, because it also occurs if cells are stimulated by the plant lectin phytohemagglutinin, a non-LPS TLR4 agonist. Our data suggest a dual mechanism of action for the peptides, not exclusively based on LPS binding and neutralization, but also on a direct effect on the LPS-binding proteins of the TLR4 receptor complex. NMR experiments in solution show that peptide addition changes the aggregation state of FP7, promoting the formation of larger micelles. These results suggest a relationship between the aggregation state of lipid A-like ligands and the type and intensity of the TLR4 response., This study was financially supported by the H2020‐MSC‐ETN‐642157 project TOLLerant. The Italian Ministry for Foreign Affairs and International Cooperation (MAECI) is acknowledged. Work at Pompeu Fabra University was supported by MINECO (grants SAF2011‐24899, AGL2014‐52395‐C2‐2‐R to D.A., CTQ2015‐64597‐C2‐1‐P and MINECO‐Severo Ochoa Excellence Acreditation 2017-2021 (SEV‐2016‐0644) to J.J.‐B.) with FEDER funds, and by Generalitat de Catalunya (2014SGR692).
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex

  • Lembo-Fazio, Luigi
  • Billod, Jean-Marc
  • Di Lorenzo, Flaviana
  • Paciello, Ida
  • Pallach, Mateusz
  • Vaz-Francisco, Sara
  • Holgado, Aurora
  • Beyaert, Rudi
  • Fresno, Manuel
  • Shimoyama, Atsushi
  • Lanzetta, Rosa
  • Fukase, Koichi
  • Gully, Djamel
  • Giraud, Eric
  • Martín-Santamaría, Sonsoles
  • Bernardini, Maria-Lina
  • Silipo, Alba
Lipopolysaccharides (LPS) are potent activator of the innate immune response through the binding to the myeloid differentiation protein-2 (MD-2)/toll-like receptor 4 (TLR4) receptor complexes. Although a variety of LPSs have been characterized so far, a detailed molecular description of the structure–activity relationship of the lipid A part has yet to be clarified. Photosynthetic Bradyrhizobium strains, symbiont of Aeschynomene legumes, express distinctive LPSs bearing very long-chain fatty acids with a hopanoid moiety covalently linked to the lipid A region. Here, we investigated the immunological properties of LPSs isolated from Bradyrhizobium strains on both murine and human immune systems. We found that they exhibit a weak agonistic activity and, more interestingly, a potent inhibitory effect on MD-2/TLR4 activation exerted by toxic enterobacterial LPSs. By applying computational modeling techniques, we also furnished a plausible explanation for the Bradyrhizobium LPS inhibitory activity at atomic level, revealing that its uncommon lipid A chemical features could impair the proper formation of the receptorial complex, and/or has a destabilizing effect on the pre-assembled complex itself.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Virtual screening approaches towards the discovery of toll-like receptor modulators

  • Pérez-Regidor, Lucía
  • Zarioh, Malik
  • Ortega, Laura
  • Martín-Santamaría, Sonsoles
34 p.-4 fig.-4 tab., This review aims to summarize the latest efforts performed in the search for novel chemical entities such as Toll-like receptor (TLR) modulators by means of virtual screening techniques. This is an emergent research field with only very recent (and successful) contributions. Identification of drug-like molecules with potential therapeutic applications for the treatment of a variety of TLR-regulated diseases has attracted considerable interest due to the clinical potential. Additionally, the virtual screening databases and computational tools employed have been overviewed in a descriptive way, widening the scope for researchers interested in the field., This work was supported by Spanish Ministry for Economy and Competitiveness (MINECO) grant CTQ2014-57141-R and Ph.D. fellowship BES-2012-053653, and by European Commission granted TOLLerant H2020-MSC-ETN-642157 project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators

  • Pérez-Regidor, Lucía
  • Zarioh, Malik
  • Ortega, Laura
  • Martín-Santamaría, Sonsoles
This review aims to summarize the latest efforts performed in the search for novel chemical entities such as Toll-like receptor (TLR) modulators by means of virtual screening techniques. This is an emergent research field with only very recent (and successful) contributions. Identification of drug-like molecules with potential therapeutic applications for the treatment of a variety of TLR-regulated diseases has attracted considerable interest due to the clinical potential. Additionally, the virtual screening databases and computational tools employed have been overviewed in a descriptive way, widening the scope for researchers interested in the field., This work was supported by Spanish Ministry for Economy and Competitiveness (MINECO) grant CTQ2014-57141-R and Ph.D. fellowship BES-2012-053653, and by European Commission granted TOLLerant H2020-MSC-ETN-642157 project. We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Computational Approaches to Toll-Like Receptor 4 Modulation

  • Billod, Jean-Marc
  • Lacetera, Alessandra
  • Guzmán-Caldentey, Joan
  • Martín-Santamaría, Sonsoles
Toll-like receptor 4 (TLR4), along with its accessory protein myeloid differentiation factor 2 (MD-2), builds a heterodimeric complex that specifically recognizes lipopolysaccharides (LPS), which are present on the cell wall of Gram-negative bacteria, activating the innate immune response. Some TLR4 modulators are undergoing preclinical and clinical evaluation for the treatment of sepsis, inflammatory diseases, cancer and rheumatoid arthritis. Since the relatively recent elucidation of the X-ray crystallographic structure of the extracellular domain of TLR4, research around this fascinating receptor has risen to a new level, and thus, new perspectives have been opened. In particular, diverse computational techniques have been applied to decipher some of the basis at the atomic level regarding the mechanism of functioning and the ligand recognition processes involving the TLR4/MD-2 system at the atomic level. This review summarizes the reported molecular modeling and computational studies that have recently provided insights into the mechanism regulating the activation/inactivation of the TLR4/MD-2 system receptor and the key interactions modulating the molecular recognition process by agonist and antagonist ligands. These studies have contributed to the design and the discovery of novel small molecules with promising activity as TLR4 modulators., We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI)., This work was supported by the Spanish Ministry for Economy and Competitiveness (MINECO) Grant CTQ2014-57141-R and PhD fellowship BES-2015-071588 and by the European Commission granted GLYCOPHARM Marie Curie ITN PITN-GA-2012-317297 (www.glycopharm.eu) and TOLLerant H2020-MSC-ETN-642157 (www.tollerant.eu) projects.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties

  • Cochet, Florent
  • Facchini, Fabio A.
  • Zaffaroni, Lenny
  • Billod, Jean-Marc
  • Coelho, Elena
  • Holgado, Aurora
  • Braun, Harald
  • Beyaert, Rudy
  • Jerala, Roman
  • Jiménez-Barbero, Jesús
  • Martín-Santamaría, Sonsoles
  • Peri, Francesco
13 p.-9 fig., New monosaccharide-based lipid A analogues were rationally designed through MD-2 docking studies. A panel of compounds with two carboxylate groups as phosphates bioisosteres, was synthesized with the same glucosamine-bis-succinyl core linked to different unsaturated and saturated fatty acid chains. The binding of the synthetic compounds to purified, functional recombinant human MD-2 was studied by four independent methods. All compounds bound to MD-2 with similar affinities and inhibited in a concentration-dependent manner the LPS-stimulated TLR4 signaling in human and murine cells, while being inactive as TLR4 agonists when provided alone. A compound of the panel was tested in vivo and was not able to inhibit the production of proinflammatory cytokines in animals. This lack of activity is probably due to strong binding to serum albumin, as suggested by cell experiments in the presence of the serum. The interesting self-assembly property in solution of this type of compounds was investigated by computational methods and microscopy, and formation of large vesicles was observed by cryo-TEM microscopy., TOLLerant project (H2020-MSC-ETN-642157), the Italian Ministry for Foreign Affairs and International Cooperation (MAECI) and Spanish MINECO (CTQ2014-57141-R and CTQ2017-88353-R grants) are acknowledged. RJ was partially funded by the research program P4-0176 by the Slovenian Research Agency., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterisation of the dynamic interactions between complex N-glycans and human CD22

  • Di Carluccio, Cristina
  • Crisman, Enrique
  • Manabe, Yoshiyuki
  • Forgione, Rosa Ester
  • Lacetera, Alessandra
  • Amato, Jussara
  • Pagano, Bruno
  • Randazzo, Antonio
  • Zampella, Angela
  • Lanzetta, Rosa
  • Fukase, Koichi
  • Molinaro, Antonio
  • Crocker, Paul R.
  • Martín-Santamaría, Sonsoles
  • Marchetti, Roberta
  • Silipo, A.
12 p.-6 fig.-1 schem., CD22 (Siglec-2) is a B-cell surface inhibitory protein capable of selectively recognising sialylated glycans, thus dampening autoimmune responses against self-antigens. Here we have characterised the dynamic recognition of complex-type N-glycans by human CD22 by means of orthogonal approaches including NMR spectroscopy, computational methods and biophysical assays. We provide new molecular insights into the binding mode of sialoglycans in complex with h-CD22, highlighting the role of the sialic acid galactose moieties in the recognition process, elucidating the conformational behaviour of complex-type N-glycans bound to Siglec-2 and dissecting the formation of CD22 homo-oligomers on the B-cell surface. Our results could enable the development of additional therapeutics capable of modulating the activity of h-CD22 in autoimmune diseases and malignancies derived from B-cells., H2020 Marie Skłodowska-Curie Actions. Grant Numbers: 642157, 814102 Mizutani Foundation for Glycoscience. Grant Number: 2014-2015, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Full-atom model of the agonist LPS-bound toll-like receptor 4 dimer in a membrane environment

  • Martín-Santamaría, Sonsoles
  • Matamoros-Recio, Alejandra
  • Franco-Gonzalez, Juan Felipe
  • Pérez-Regidor, Lucía
  • Billod, Jean-Marc
  • Guzmán-Caldentey, Joan
21 p.-14 fig. In Memoriam Prof. Kilian Muñiz (R.I.P.). Excellent person, great heart., The innate immunity TLR4/MD-2 system is a membrane receptor of paramount importance as therapeutic target. Its assembly, upon binding of Gram-negative bacteria lipopolysaccharide (LPS), and also dependent on the membrane composition, finally triggers the immune response cascade. We here combine ab-initio calculations, molecular docking, all-atom molecular dynamics simulations, and thermodynamics calculations to provide the most realistic and complete 3D models of the active full TLR4 complex embedded into a realistic membrane to date. Our studies reveal functional and structural insights into the transmembrane domain behavior in different membrane environments, the ectodomain bouncing movement, and the dimerization patterns of the intracellular TIR domain. Our work provides TLR4 models as reasonable 3D structures for the (TLR4/MD-2/LPS) 2 architecture accounting for the active (agonist) state of the TLR4, and pointing to a signal transduction mechanism across cell membrane. These observations unveil relevant molecular aspects involved in the TLR4 innate immune pathways and will promote the discovery of new TLR4 modulators., This work was financially supported by the Spanish Ministry for Science and Innovation (grants CTQ2014-57141-R, CTQ2017-88353-R, and PID2020-113588RB-I00; grants BES-2012-053653 for L.P.R., BES-2015-071588 for J.G.C. and PRE2018-086249 for A.M.R.), and the European Commission Marie Sklodowska-Curie actions (H2020-MSCA-ITN 642157 “TOLLerant”)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Co-administration of antimicrobial peptides enhances toll-like receptor 4 antagonist activity of a synthetic glycolipid

  • Facchini, Fabio A.
  • Coelho, Helena
  • Sestito, Stefania Enza
  • Delgado, Sandra
  • Minotti, Alberto
  • Andreu Martínez, David
  • Jiménez-Barbero, Jesús J.
  • Peri, Francesco
This study examines the effect of co-administration of antimicrobial peptides and the synthetic glycolipid FP7, which is active in inhibiting inflammatory cytokine production caused by TLR4 activation and signaling. The co-administration of two lipopolysaccharide (LPS)-neutralizing peptides (a cecropin A-melittin hybrid peptide and a human cathelicidin) enhances by an order of magnitude the potency of FP7 in blocking the TLR4 signal. Interestingly, this is not an additional effect of LPS neutralization by peptides, because it also occurs if cells are stimulated by the plant lectin phytohemagglutinin, a non-LPS TLR4 agonist. Our data suggest a dual mechanism of action for the peptides, not exclusively based on LPS binding and neutralization, but also on a direct effect on the LPS-binding proteins of the TLR4 receptor complex. NMR experiments in solution show that peptide addition changes the aggregation state of FP7, promoting the formation of larger micelles. These results suggest a relationship between the aggregation state of lipid A-like ligands and the type and intensity of the TLR4 response., This study was financially supported by the H2020‐MSC‐ETN‐642157 project TOLLerant. The Italian Ministry for Foreign Affairs and International Cooperation (MAECI) is acknowledged. Work at Pompeu Fabra University was supported by MINECO (grants SAF2011‐24899, AGL2014‐52395‐C2‐2‐R to D.A., CTQ2015‐64597‐C2‐1‐P and MINECO‐Severo Ochoa Excellence Acreditation 2017-2021 (SEV‐2016‐0644) to J.J.‐B.) with FEDER funds, and by Generalitat de Catalunya (2014SGR692).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SIMPLE: structured illumination based point localization estimator with enhanced precision

  • Reymond, Loïc
  • Ziegler, Johannes
  • Knapp, Christian
  • Wang, Fung-Chen
  • Huser, Thomas
  • Ruprecht, Verena
  • Wieser, Stefan
We present a structured illumination microscopy based point localization estimator (SIMPLE) that achieves a 2-fold increase in single molecule localization precision compared to conventional centroid estimation methods. SIMPLE advances the recently introduced MINFLUX concept by using precisely phase-shifted sinusoidal wave patterns as nanometric rulers for simultaneous particle localization based on photon count variation over a 20 μm field of view. We validate SIMPLE in silico and experimentally on a TIRF-SIM setup using a digital micro-mirror device (DMD) as a spatial light modulator., Funding: “la Caixa” Foundation (ID 100010434, LCF/BQ/IN18/11660032); Marie Skłodowska-Curie Horizon 2020 (713673, 754558, 642157); Spanish Ministry Centro de Excelencia Severo Ochoa (SEV-2015-0522); MINECO’s Plan Nacional (BFU2017-86296-P); Generalitat de Catalunya (CERCA); Fundació Privada Cellex